Comparison Overview
Gilead Sciences Italia

Gilead Sciences Italia
N/A
Last Update: 31/03/2026
Gilead Sciences è una società biofarmaceutica basata impegnata nella ricerca, sviluppo e commercializzazione di farmaci innovativi per patologie molto gravi. Le aree terapeutiche sulle quali ci concentriamo comprendono HIV/AIDS, le malattie epatiche, ematologiche e onco...

Alembic Pharmaceuticals Limited
Alembic Road, Vadodara, 390003, IN
Last Update: 01/04/2026
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is t...
Compliance Ranges Comparison

Gilead Sciences Italia







Alembic Pharmaceuticals Limited






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Gilead Sciences Italia in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Alembic Pharmaceuticals Limited in 2026.
Incident History - Gilead Sciences Italia (X = Date, Y = Severity)
Gilead Sciences Italia cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Alembic Pharmaceuticals Limited (X = Date, Y = Severity)
Alembic Pharmaceuticals Limited cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Gilead Sciences Italia

Alembic Pharmaceuticals Limited
FAQ
Latest Global CVEs
Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.
Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.
Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.
Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.
Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.